Optomed, based in Finland is a leading provider and manufacturer of Fundus Cameras, Screening Software and Artificial Intellengence (AI) Solutions.
Optomed is a publicly listed medical technology company and a leading provider of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with screening software and artificial intelligence (AI) with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. Optomed’s products are used in private clinics, public hospitals, primary care, non-government organizations and charities in over 60 countries globally, and our camera products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China) for Smartscope PRO. Optomed was founded in 2004 in Finland.
The company has an extensive portfolio of +50 international patents protecting the technology and the company employs over 100 professionals focusing on R&D and sales of fundus cameras, screening software and AI solutions.
Our mission is to provide innovative and affordable products and software solutions that enable screening and eye examinations for everyone.
Mr. Arto Peura